The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

New Zealand’s Medical Research Institute has found that Celebrex users are nearly twice as likely to suffer a heart attack as those taking other arthritis drugs, commonly known as Cox-2 inhibitors. Last August, Pfizer, the manufacturer of Celebrex, put a “black box” warning on the drug yet Celebrex stayed on the market. The black box warning is the most severe of the labels placed on pharmaceutical drugs. Celebrex remains the only Cox-2 inhibitor still on the market today.

Comments are closed.

Of Interest